Many view the yield curve steepening as a recession confirmation indicator, but the signal is not that reliable. However, the sudden steepening does add to other data that also suggests recession.

With unemployment rate at 4.3% (beating expectations by 0.2%), this is roughly where it‘s usually starting to rise faster in the months ahead as temps and overtime go-tos have been depleted already.

It is hard for me to rationalize Friday's total market collapse based on the continuing facts on the ground

The market has enjoyed a great 2024 so far, with a resilient economy and favorable earnings results providing positive tailwinds. However, the positivity hasn’t been felt by all stocks, including apparel favorite Nike. Is it due for a comeback?

The S&P 500 witnessed a rather varied performance throughout the month of July. The month started with upward momentum from late June, before peaking around mid-July at approximately 5,680.

The storm passing across Northern Florida is expected to move back into the Atlantic around the Aug. 6-8 timeframe. This would leave the remainder of the Central US in an arid weather trend.

Berkshire Hathaway recently released its Form 10-Q report for the second quarter. Here are some brief highlights from the release.

In this video, I review some recent trades from the past week. I also discuss how to navigate the market when risks are elevated.

After the publication of US non-farm payrolls data, Bloomberg reported that the likelihood of a 50 basis points rate hike in September increased to 90%. Consequently, the EUR/USD pair soared to 1.0926, then finished the working week at 1.0910.

Every earnings season has its own unique set of expectations and realities. Coming into this earnings season, one of the most intriguing questions was how well the consumer-facing companies would be able to maintain their pricing power.

Consumers are holding on to their cars longer and are increasingly making minor repairs to keep cars on the road for longer. As average costs for vehicle repair increase when a car ages, this directly benefits Genuine Parts Company.

Shanghai ImmuneOnco Biopharma out-licensed global rites (ex-China) for two of its antibodies to Instil Bio of Dallas, Texas. ImmuneOnco will receive an upfront and near-term payments of $50 million, and up to more than $2 billion in milestones.